Alaunos Therapeutics Insider Trades

NASDAQ: TCRTHealth CareBiotechnology: Pharmaceutical PreparationsUSD

0.7858+0.0048 (+0.61%)

At close: Oct 9, 4:00 PM ET · Delayed 15 min

Last 12 months

Purchases: 0 · $0
Sales: 0 · $0
Shares bought / sold: 0 / 0
Net activity: Net buying $0

Alaunos Therapeutics insider activity

Over the last 12 months, Alaunos Therapeutics insiders reported 4 transactions on SEC Form 4: 0 open-market purchases and 0 sales. The most recent filing shows Postma Robert W (Director) reporting a transaction in 21,829 shares at $0.7444 on Oct 6, 2026. Insider sales are common for compensation, tax and diversification reasons, while open-market purchases are rarer; tracking both helps put TCRT's ownership changes in context.

Summary generated from market data by MetaCap's automated system. Methodology

TCRT insider transactions

Alaunos Therapeutics insider transactions
Date	Insider	Type	Shares	Price	Value	Owned after	Filing
Oct 6, 2026	Jerman Michael AllenDirector	Award	20,990	$0.7444	$15.62K	44.75K	Form 4
Oct 6, 2026	Vieser JaimeDirector	Award	22,669	$0.7444	$16.87K	70.31K	Form 4
Oct 6, 2026	Weis HolgerCEO	Award	23,564	$0.7444	$17.54K	49.05K	Form 4
Oct 6, 2026	Postma Robert WDirector	Award	21,829	$0.7444	$16.25K	80.44K	Form 4

Transaction codes follow SEC Form 4: P = open-market purchase, S = open-market sale, A = grant or award, M = option exercise, F = shares withheld for taxes. About Form 4